SequelSEC

TAO Synergies Inc. TAOX

Finance Services · CIK 0001571934 · Fiscal year ends 1231 · Bank

AnnualQuarterlyTTM
Revenue
$88.63K
Fiscal year ended 2026-06-30
Net income
-$9.30M
Fiscal year ended 2026-06-30
Total assets
$21.10M
Fiscal year ended 2026-06-30

TAO Synergies Inc. (TAOX) reported revenue of $88.63K and net income of -$9.30M for the fiscal year ended 2026-06-30. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from TAO Synergies Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Finance Services.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

TAO Synergies Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-31
Revenue$88.63K$388.77KUnavailable$203.37K$3.96KUnavailable
Cost of revenue$22.06K$17.37KUnavailableUnavailableUnavailableUnavailable
Gross profit$66.56K$371.40KUnavailableUnavailableUnavailableUnavailable
Operating income-$1.57M-$1.32MUnavailable-$1.80M-$3.04MUnavailable
Net income-$9.30M$4.25MUnavailable-$3.92M-$17.52MUnavailable
Research & development$31.86K$28.60KUnavailable$54.39K$148.56KUnavailable
Weighted-average diluted sharesshares 7.47Mshares 7.70MUnavailableshares 2.55Mshares 1.57MUnavailable
Pretax income-$9.30M$4.25MUnavailable-$3.92M-$17.52MUnavailable
Income tax expense$0$0UnavailableUnavailable$0Unavailable
Diluted EPS$-1.83$0.43Unavailable$-1.56$-11.26Unavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$1.63M$1.68MUnavailable$1.95M$2.19MUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

TAO Synergies Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-31
Cash & equivalents$2.37M$3.65M$5.50MUnavailable$14.37M$17.66M
Total assets$21.10M$31.05M$25.84M$18.36M$19.79M$17.73M
Current assets$20.62M$30.24M$25.38M$18.35M$19.78M$17.72M
Total liabilities$3.81M$4.88M$3.94M$1.69M$1.83M$10.96M
Current liabilities$1.03M$1.10M$1.81M$1.04M$964.26K$1.01M
Total equity incl. NCI$12.75M$23.26M$21.05M$16.07M$17.25M$5.86M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailable$912.83K
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$899.18K$946.33K$1.18M$949.65K$898.15K$317.29K

Cash flow

TAO Synergies Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-31
Operating cash flow-$874.98K-$1.68MUnavailable-$1.19MUnavailableUnavailable
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailable-$13.07MUnavailableUnavailable
Financing cash flow-$402.37K-$169.01KUnavailable$1.34MUnavailableUnavailable
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$735$816Unavailable$803UnavailableUnavailable

Derived

TAO Synergies Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302024-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin75.1%95.5%UnavailableUnavailableUnavailableUnavailable
Operating margin-1770.6%-339.0%Unavailable-884.8%-76623.8%Unavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio19.99x27.40x13.99x17.61x20.51x17.47x
Revenue YoY growth2136.9%UnavailableUnavailableUnavailableUnavailableUnavailable
Net margin-10492.4%1094.3%Unavailable-1929.1%-442101.9%Unavailable
R&D / revenue35.9%7.4%Unavailable26.7%3749.5%Unavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailable0.0%UnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open TAOX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-K/A · Filed 2026-06-05View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing

Companies in the same industry

Reconciliation checks needing review

2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2026-06-30

Difference 4544681 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2026-03-31

Difference 2905858 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.